FRANCISCO JOSE HERMIDA PRADO-rekin lankidetzan egindako argitalpenak (3)

2024

  1. Tumor mutational burden predictability in head and neck squamous cell carcinoma patients treated with immunotherapy: systematic review and meta-analysis

    Journal of translational medicine, Vol. 22, Núm. 1, pp. 135

2016

  1. Impact of PI3K/AKT/mTOR pathway activation on the prognosis of patients with head and neck squamous cell carcinomas

    Oncotarget, Vol. 7, Núm. 20, pp. 29780-29793

2015

  1. Clinical significance of Anoctamin-1 gene at 11q13 in the development and progression of head and neck squamous cell carcinomas

    Scientific Reports, Vol. 5